The Safety and Clinical Efficacy of RAK Cell Therapy in Late-stage Gastric Cancer: A Randomized Controlled Trial
Clinical trial NCT07212933 · RECRUITING
Trial details
- NCT number
- NCT07212933
- Sponsor
- Chinese PLA General Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-01
- Primary completion
- 2027-12-31
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.